Evidence map›Paper›PMID 36621005›Full record

ArticleDevelopment (Cambridge, England)2023

NANOGP1, a tandem duplicate of NANOG, exhibits partial functional conservation in human naïve pluripotent stem cells.

Katsiaryna Maskalenka, Gökberk Alagöz, Felix Krueger, Joshua Wright, Maria Rostovskaya, Asif Nakhuda, Adam Bendall, Christel Krueger, Simon Walker, Aylwyn Scally and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Development (Cambridge, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. CD4Science advances · 2025
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Katsiaryna MaskalenkaEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK.
Gökberk AlagözDepartment of Genetics, University of Cambridge, Cambridge CB2 3EH, UK.
Felix KruegerBioinformatics Group, Babraham Institute, Cambridge CB22 3AT, UK.
Joshua WrightEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK.
Maria RostovskayaEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK.
Asif NakhudaGene Targeting Facility, Babraham Institute, Cambridge CB22 3AT, UK.
Adam BendallEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK.
Christel KruegerEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK.
Simon WalkerImaging Facility, Babraham Institute, Cambridge CB22 3AT, UK.
Aylwyn ScallyDepartment of Genetics, University of Cambridge, Cambridge CB2 3EH, UK.
Peter J Rugg-GunnEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK.ORCID 0000-0002-9601-5949
Babraham Institute · GBUniversity of Cambridge · GB

Funding

Biotechnology and Biological Sciences Research Council BBS/E/B/000C0421Medical Research Council MR/T011769/1Medical Research Council MR/V02969X/1Wellcome TrustWellcome Trust 215116/Z/18/Z
6 · The paper itself

Abstract

Gene duplication events can drive evolution by providing genetic material for new gene functions, and they create opportunities for diverse developmental strategies to emerge between species. To study the contribution of duplicated genes to human early development, we examined the evolution and function of NANOGP1, a tandem duplicate of the transcription factor NANOG. We found that NANOGP1 and NANOG have overlapping but distinct expression profiles, with high NANOGP1 expression restricted to early epiblast cells and naïve-state pluripotent stem cells. Sequence analysis and epitope-tagging revealed that NANOGP1 is protein coding with an intact homeobox domain. The duplication that created NANOGP1 occurred earlier in primate evolution than previously thought and has been retained only in great apes, whereas Old World monkeys have disabled the gene in different ways, including homeodomain point mutations. NANOGP1 is a strong inducer of naïve pluripotency; however, unlike NANOG, it is not required to maintain the undifferentiated status of human naïve pluripotent cells. By retaining expression, sequence and partial functional conservation with its ancestral copy, NANOGP1 exemplifies how gene duplication and subfunctionalisation can contribute to transcription factor activity in human pluripotency and development.

Indexed as

Genes, HomeoboxPluripotent Stem CellsAnimalsHomeodomain ProteinsHumansNanog Homeobox ProteinTranscription FactorsHomeodomain ProteinsNanog Homeobox ProteinNANOGP1 protein, humanNANOG protein, humanTranscription FactorsEvolutionGene duplicationPluripotencyPseudogeneReprogrammingTranscription factor

Identifiers

PMID36621005
PMCPMC10110494
OpenAlexW4313826409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.